Conversely, c-Met silencing in MDA-MB-231 cells, showed that c-Met inhibition in breast cancer cells severely impaired tumorigenic potential of ASCs (Fig.7 MDA-MB-231shMet). This evidence concerns the gene MET and breast cancer.